Home > Healthcare > Orthobiologics Market > Table of Contents

Orthobiologics Market - By Product Type (Viscosupplementation, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Platelet-Rich Plasma), Application (Spinal Fusion, Soft-tissue Injuries), End-use & Forecast, 2024 - 2032

  • Report ID: GMI9311
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing incidence of spinal disorders

3.2.1.2    Surging cases of orthopedic and sports injuries

3.2.1.3    Growing preference for minimally invasive procedures

3.2.1.4    Increasing prevalence of various bone diseases

3.2.2    Industry pitfalls & challenges

3.2.2.1    High costs associated with orthobiologic-based treatments

3.2.2.2    Clinical limitations of various orthobiologics

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Reimbursment scenerio

3.6    Technological landscape

3.7    Start-up scenario

3.8    Porter’s analysis

3.9    PESTEL analysis

3.10    Future market trends

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Viscosupplementation products

5.2.1    Single injection

5.2.2    Three injection

5.2.3    Five injection

5.3    Demineralized bone matrices

5.4    Synthetic orthobiologics

5.5    Bone morphogenic protein

5.6    Allografts

5.7    Platelet-rich plasma (PRP)

5.8    Other product types

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Spinal fusion

6.3    Soft-tissue injuries

6.4    Osteoarthritis and degenerative arthritis

6.5    Other applications

Chapter 7   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Hospitals and orthopedic clinics

7.3    Ambulatory surgical centers

7.4    Research and academic institutes

7.5    Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Netherlands

8.3.7    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Rest of Latin America

8.6    Middle East and Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Anika Therapeutics, Inc.

9.2    Arthrex Inc.

9.3    Bioventus LLC

9.4    Depuy Synthes (JnJ)

9.5    Globus Medical Inc.

9.6    Medtronic PLC

9.7    NuVasive Inc.

9.8    Orthofix Medical Inc.

9.9    RTI Surgical

9.10    Seaspine Holdings Corporation

9.11    Stryker Corporation

9.12    Zimmer Biomet

   

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 149
  • Countries covered: 23
  • Pages: 100
 Download Free Sample